Drugs / TU 025 Keishi Bukuryo Gan
TU 025 Keishi Bukuryo Gan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00119418 | Nov 2004 → Feb 2006 | — | Plotnikoff, Gregory A., M.D. | Completed | Missed primary |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TU 025 Keishi Bukuryo Gan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00119418 ↗ |
| Known as | keishibukuryogan | “The aim of this study was to assess the efficacy of TU-025, keishibukuryogan, a Japanese prescription herbal medicine used for hot flash management, in American women.” PMID 21738077 ↗ Aug 2011 |
| Known as | TJ25 | “In Japan, TJ25 Keishi Bukuryo Gan is a leading non-hormonal prescription agent for management of menopausal hot flashes.” NCT00119418 ↗ |
| Known as | TU-025 | “The aim of this study was to assess the efficacy of TU-025, keishibukuryogan, a Japanese prescription herbal medicine used for hot flash management, in American women.” PMID 21738077 ↗ Aug 2011 |
| Known as | TU-25 | “This is a pilot phase II clinical study to estimate the effectiveness of TU-25 Keishi Bukuryo Gan for reduction of both the severity and the frequency of hot flashes in healthy...” NCT00119418 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “TU-025, keishibukuryogan, a Japanese prescription herbal medicine used for hot flash management” PMID 21738077 ↗ Aug 2011 |